July 14, 2010 8:46 AM
- Text
Glaxo to Pay $460 M to Resolve Avandia Lawsuits
Avandia tablet bottle (AP)
(CBS)
Bloomberg reported Tuesday that GlaxoSmithKline, the company that makes the diabetes drug Avandia, has agreed to pay around $460 million to resolve most of the lawsuits alleging the drug causes strokes and heart attacks.
GlaxoSmithKline has faced more than 13,000 lawsuits alleging that Glaxo hid Avandia's heart-attack risk. The first Avandia trial is set for October in Philadelphia in federal court.
Read the Bloomberg story here.
An FDA panel met Tuesday to spend two days listening to more than 20 experts and sorting through 700 pages of data trying to determine whether Avandia causes heart attacks and deaths and should be pulled from the market, reports CBS News medical correspondent Dr. Jon LaPook.
GlaxoSmithKline official Dr. Murray Stewart told the committee their drug is safe "and should remain a treatment option for patients with type 2 Diabetes."
But other experts disagreed vehemently, saying the evidence clearly shows Avandia is dangerous.
The trustworthiness of the company was called into question when Senate investigators released documents Tuesday showing the company knew about problems 11 years ago but didn't make them public.
More on Avandia:
Will Avandia Be Pulled from the Market?
a>
Could Avandia Be Pulled?
Avandia Maker Hid Risks for Years, Probe Finds
Diabetes Drug to Get Second Look
GlaxoSmithKline has faced more than 13,000 lawsuits alleging that Glaxo hid Avandia's heart-attack risk. The first Avandia trial is set for October in Philadelphia in federal court.
Read the Bloomberg story here.
An FDA panel met Tuesday to spend two days listening to more than 20 experts and sorting through 700 pages of data trying to determine whether Avandia causes heart attacks and deaths and should be pulled from the market, reports CBS News medical correspondent Dr. Jon LaPook.
GlaxoSmithKline official Dr. Murray Stewart told the committee their drug is safe "and should remain a treatment option for patients with type 2 Diabetes."
But other experts disagreed vehemently, saying the evidence clearly shows Avandia is dangerous.
The trustworthiness of the company was called into question when Senate investigators released documents Tuesday showing the company knew about problems 11 years ago but didn't make them public.
More on Avandia:
Will Avandia Be Pulled from the Market?
a>
Could Avandia Be Pulled?
Avandia Maker Hid Risks for Years, Probe Finds
Diabetes Drug to Get Second Look
Popular Now in Health
- Electronic cigarette explodes in man's mouth
- Skin cancer self-exam: What to look for (PHOTOS)
- Report: 400 types of lipstick contain lead
- Whitney Houston's autopsy: What's taking so long?
- All infant Tylenol recalled by J&J
- Christina Hendricks: Too Big for Hollywood?
- Things You Didn't Know About Your Penis
- Anti-Rape Condoms Fight World Cup Sex Assault
- PICTURES: 15 Shocking Sexual Fetishes
- HealthPop: Indulging, diagnosing and dying
- 8 Tips For Losing Weight After Pregnancy
- Caffeine inhalers - the next club drug?
- Heart Attack Grill owner responds to incident
- Cancer drug reverses Alzheimer's in mice: Study
- Mars to set calorie limit on chocolate bars
- New study is wake-up call for diet soda drinkers
- Orgasm Just by Thinking: Medically Possible?
Latest CBS News Headlines
on Facebook Most Discussed Stories
on CBS News
- Medco Health Solutions 4Q profit climbs 12 percent
- US-SKorea free trade pact to take effect in March
- Embrace risk, but only over the long haul
- Retirement tips: Here's how to save more now
on Facebook Most Discussed Stories
on CBS News






